(2R,3R,4R,5R)-2,5-bis[(E)-3-bromoprop-2-enoxy]-3,4-dihydroxy-N-[(1R,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5-(5-methyl-1,3,4-oxadiazol-2-yl)pentanamide
Molecular Formula:
C23H27Br2N3O7
InChI: InChI=1/C23H27Br2N3O7/c1-13-27-28-23(35-13)21(34-11-5-9-25)19(31)18(30)20(33-10-4-8-24)22(32)26-17-15-7-3-2-6-14(15)12-16(17)29/h2-9,16-21,29-31H,10-12H2,1H3,(H,26,32)/b8-4+,9-5+/t16-,17+,18-,19-,20-,21-/m1/s1/f/h26H
InChIKey: InChIKey=QNXNBPWDSBECNL-CTBBOWQYDO
SMILES: CC1=NN=C(O1)C(C(C(C(C(=O)NC2C(CC3=CC=CC=C23)O)OCC=CBr)O)O)OCC=CBr
Names:
(2R,3R,4R,5R)-2,5-bis[(E)-3-bromoprop-2-enoxy]-3,4-dihydroxy-N-[(1R,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-5-(5-methyl-1,3,4-oxadiazol-2-yl)pentanamide
Registries:
PubChem CID 11541810
PubChem ID 16643849
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|